The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Herbert Y. Meltzer

1601 23rd Ave South

Ste 3035

Nashville

TN 37212-8645

USA

[email]@vanderbilt.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • 1601 23rd Ave South, Ste 3035, Nashville, TN 37212-8645, USA. 2011
  • Vanderbilt Psychiatric Hospital, 1601 23rd Ave South, Suite 306, Nashville. 2004 - 2011
  • Vanderbilt University School of Medicine, Department of Psychiatry, 1601 23rd Avenue South, Suite 306, USA. 2011
  • Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN 37212, USA. 2003 - 2011
  • Vanderbilt University School of Medicine, USA. 2005

References

  1. A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: influence of valproic acid augmentation. Meltzer, H.Y., Bonaccorso, S., Bobo, W.V., Chen, Y., Jayathilake, K. J. Clin. Psychiatry (2011) [Pubmed]
  2. The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. Horiguchi, M., Huang, M., Meltzer, H.Y. J. Pharmacol. Exp. Ther. (2011) [Pubmed]
  3. The role of serotonin receptors in the action of atypical antipsychotic drugs. Meltzer, H.Y., Massey, B.W. Curr. Opin. Pharmacol (2011) [Pubmed]
  4. The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Meltzer, H.Y., Horiguchi, M., Massey, B.W. Psychopharmacology (Berl.) (2011) [Pubmed]
  5. Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis. Meltzer, H.Y., Mills, R., Revell, S., Williams, H., Johnson, A., Bahr, D., Friedman, J.H. Neuropsychopharmacology (2010) [Pubmed]
  6. Asenapine. Meltzer, H.Y., Dritselis, A., Yasothan, U., Kirkpatrick, P. Nat. Rev. Drug. Discov (2009) [Pubmed]
  7. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Meltzer, H.Y., Huang, M. Prog. Brain Res. (2008) [Pubmed]
  8. Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorder. Meltzer, H.Y., Brennan, M.D., Woodward, N.D., Jayathilake, K. Schizophr. Res. (2008) [Pubmed]
  9. Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies. Meltzer, H.Y., Bobo, W.V., Nuamah, I.F., Lane, R., Hough, D., Kramer, M., Eerdekens, M. J. Clin. Psychiatry (2008) [Pubmed]
  10. Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? Meltzer, H.Y., Sumiyoshi, T. Behav. Brain Res. (2008) [Pubmed]
  11. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia. Meltzer, H.Y., Bobo, W.V., Roy, A., Jayathilake, K., Chen, Y., Ertugrul, A., Anil Yağcioğlu, A.E., Small, J.G. J. Clin. Psychiatry (2008) [Pubmed]
  12. Interpreting the efficacy findings in the CATIE study: what clinicians should know. Meltzer, H.Y., Bobo, W.V. CNS. Spectr (2006) [Pubmed]
  13. Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: are there differences?. Meltzer, H.Y. Int. J. Neuropsychopharmacol. (2005) [Pubmed]
  14. Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine. Meltzer, H.Y. J. Clin. Psychiatry (2005) [Pubmed]
  15. What's atypical about atypical antipsychotic drugs?. Meltzer, H.Y. Curr. Opin. Pharmacol (2004) [Pubmed]
  16. Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. Meltzer, H.Y., Arvanitis, L., Bauer, D., Rein, W. Am. J. Psychiatry (2004) [Pubmed]
  17. Cognitive factors in schizophrenia: causes, impact, and treatment. Meltzer, H.Y. CNS. Spectr (2004) [Pubmed]
  18. Serotonin receptors: their key role in drugs to treat schizophrenia. Meltzer, H.Y., Li, Z., Kaneda, Y., Ichikawa, J. Prog. Neuropsychopharmacol. Biol. Psychiatry (2003) [Pubmed]
 
WikiGenes - Universities